Cargando…
Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study
BACKGROUND: Systemic inflammation and cachexia are associated with adverse clinical outcomes in elderly patients with cancer. The survival outcomes of elderly patients with cancer cachexia (EPCC) with high inflammation and a high risk of mortality are unknown. This study aimed to investigate the imp...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558830/ https://www.ncbi.nlm.nih.gov/pubmed/34737602 http://dx.doi.org/10.2147/JIR.S332408 |
_version_ | 1784592644067819520 |
---|---|
author | Ruan, Guo-Tian Yang, Ming Zhang, Xiao-Wei Song, Meng-Meng Hu, Chun-Lei Ge, Yi-Zhong Xie, Hai-Lun Liu, Tong Tang, Meng Zhang, Qi Zhang, Xi Zhang, Kang-Ping Li, Xiang-Rui Li, Qin-Qin Chen, Yong-Bing Yu, Kai-Ying Cong, Ming-Hua Wang, Kun-Hua Shi, Han-Ping |
author_facet | Ruan, Guo-Tian Yang, Ming Zhang, Xiao-Wei Song, Meng-Meng Hu, Chun-Lei Ge, Yi-Zhong Xie, Hai-Lun Liu, Tong Tang, Meng Zhang, Qi Zhang, Xi Zhang, Kang-Ping Li, Xiang-Rui Li, Qin-Qin Chen, Yong-Bing Yu, Kai-Ying Cong, Ming-Hua Wang, Kun-Hua Shi, Han-Ping |
author_sort | Ruan, Guo-Tian |
collection | PubMed |
description | BACKGROUND: Systemic inflammation and cachexia are associated with adverse clinical outcomes in elderly patients with cancer. The survival outcomes of elderly patients with cancer cachexia (EPCC) with high inflammation and a high risk of mortality are unknown. This study aimed to investigate the impact of high inflammation on the prognosis of EPCC patients with high mortality. PATIENTS AND METHODS: This multicenter cohort study included 746 EPCC (age >65 years) with a mean age of 72.00 ± 5.24 years, of whom 489 (65.5%) were male. The cut-off value for the inflammation index was obtained using the optimal survival curve. The different inflammatory indicators were assessed using the concordance index (C-index), decision curve analysis (DCA), and prognostic receiver operating characteristic (ROC). The high mortality risk group of EPCC was defined by the 2011 Fearon Cancer Diagnostic Consensus. EPCC were divided into the high-risk group, which satisfies three diagnostic criteria, and a low-risk group, which satisfies only one or two diagnostic criteria. RESULTS: The C-index, DCA, and prognostic ROC indicated the superiority of advanced lung cancer inflammation index (ALI) compared with other indicators, including neutrophil–lymphocyte ratio (NLR), prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and platelet–lymphocyte ratio (PLR). Whether ALI was used as a continuous or a categorical variable, ALI had a better prognostic value in EPCC compared with other inflammatory indicators. In particular, patients with low ALI (<25.03) had a worse overall survival (OS) than patients with high ALI (≥25.03) (P < 0.001, HR [95% CI] = 2.092 [1.590–2.751]). The combination effect analysis showed that the risk of mortality of the patients in the low-ALI and high-risk groups was 3.095-fold higher than that of patients in the high-ALI and low-risk groups. CONCLUSION: The prognostic and discriminative value of the inflammatory indicator ALI was better than that of NLR, PNI, SII, and PLR in EPCC. The high-risk group of EPCC with a low ALI would increase the death risk of OS. |
format | Online Article Text |
id | pubmed-8558830 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85588302021-11-03 Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study Ruan, Guo-Tian Yang, Ming Zhang, Xiao-Wei Song, Meng-Meng Hu, Chun-Lei Ge, Yi-Zhong Xie, Hai-Lun Liu, Tong Tang, Meng Zhang, Qi Zhang, Xi Zhang, Kang-Ping Li, Xiang-Rui Li, Qin-Qin Chen, Yong-Bing Yu, Kai-Ying Cong, Ming-Hua Wang, Kun-Hua Shi, Han-Ping J Inflamm Res Original Research BACKGROUND: Systemic inflammation and cachexia are associated with adverse clinical outcomes in elderly patients with cancer. The survival outcomes of elderly patients with cancer cachexia (EPCC) with high inflammation and a high risk of mortality are unknown. This study aimed to investigate the impact of high inflammation on the prognosis of EPCC patients with high mortality. PATIENTS AND METHODS: This multicenter cohort study included 746 EPCC (age >65 years) with a mean age of 72.00 ± 5.24 years, of whom 489 (65.5%) were male. The cut-off value for the inflammation index was obtained using the optimal survival curve. The different inflammatory indicators were assessed using the concordance index (C-index), decision curve analysis (DCA), and prognostic receiver operating characteristic (ROC). The high mortality risk group of EPCC was defined by the 2011 Fearon Cancer Diagnostic Consensus. EPCC were divided into the high-risk group, which satisfies three diagnostic criteria, and a low-risk group, which satisfies only one or two diagnostic criteria. RESULTS: The C-index, DCA, and prognostic ROC indicated the superiority of advanced lung cancer inflammation index (ALI) compared with other indicators, including neutrophil–lymphocyte ratio (NLR), prognostic nutritional index (PNI), systemic immune-inflammation index (SII), and platelet–lymphocyte ratio (PLR). Whether ALI was used as a continuous or a categorical variable, ALI had a better prognostic value in EPCC compared with other inflammatory indicators. In particular, patients with low ALI (<25.03) had a worse overall survival (OS) than patients with high ALI (≥25.03) (P < 0.001, HR [95% CI] = 2.092 [1.590–2.751]). The combination effect analysis showed that the risk of mortality of the patients in the low-ALI and high-risk groups was 3.095-fold higher than that of patients in the high-ALI and low-risk groups. CONCLUSION: The prognostic and discriminative value of the inflammatory indicator ALI was better than that of NLR, PNI, SII, and PLR in EPCC. The high-risk group of EPCC with a low ALI would increase the death risk of OS. Dove 2021-10-27 /pmc/articles/PMC8558830/ /pubmed/34737602 http://dx.doi.org/10.2147/JIR.S332408 Text en © 2021 Ruan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Ruan, Guo-Tian Yang, Ming Zhang, Xiao-Wei Song, Meng-Meng Hu, Chun-Lei Ge, Yi-Zhong Xie, Hai-Lun Liu, Tong Tang, Meng Zhang, Qi Zhang, Xi Zhang, Kang-Ping Li, Xiang-Rui Li, Qin-Qin Chen, Yong-Bing Yu, Kai-Ying Cong, Ming-Hua Wang, Kun-Hua Shi, Han-Ping Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study |
title | Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study |
title_full | Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study |
title_fullStr | Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study |
title_full_unstemmed | Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study |
title_short | Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia – Results from a Multicenter Study |
title_sort | association of systemic inflammation and overall survival in elderly patients with cancer cachexia – results from a multicenter study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558830/ https://www.ncbi.nlm.nih.gov/pubmed/34737602 http://dx.doi.org/10.2147/JIR.S332408 |
work_keys_str_mv | AT ruanguotian associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT yangming associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT zhangxiaowei associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT songmengmeng associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT huchunlei associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT geyizhong associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT xiehailun associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT liutong associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT tangmeng associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT zhangqi associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT zhangxi associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT zhangkangping associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT lixiangrui associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT liqinqin associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT chenyongbing associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT yukaiying associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT congminghua associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT wangkunhua associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy AT shihanping associationofsystemicinflammationandoverallsurvivalinelderlypatientswithcancercachexiaresultsfromamulticenterstudy |